New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Public trust part of the life sciences supply chain mix

Complexities in the pharmaceutical, medical device, and biologics supply chain surpass any other industry, except nuclear power. Million-dollar pallets, toxic oncology meds, longer shipping channels—even the public trust, are part of the mix.

For the May/June print issue, Healthcare Packaging goes to Washington, Europe, and to a local FDA event, to take the pulse of the regulatory, compliance, processing, and packaging “links” in the life sciences supply chain.

Quality problems in successful batch production, continuing packaging materials challenges including developments in materials sciences to deal with leachables, extractables, delamination, elastomers—and even workforce development issues around the globe are impacting the drug supply chain. (Singapore is offering tax advantages for biologics manufacturers but needs to train regulatory officials to direct these efforts.)

Supply chain boundaries are stretching, and even the definitions of words like “quality” need to be agreed upon and readers are seeking more standards. Chemicals and excipients used in pharmaceutical processing also pose supply chain quality issues. This leads me to ask, “What is life sciences packaging?“ Where does it begin, where does it end?

We continue to explore all pertinent issues to this complex supply chain. Come explore with us—in print, and online.

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts